Athira Pharma Executives' Stock Trades: Buy and Sell Activity

Athira Pharma, Inc. [ATHA] recently disclosed insider transactions involving key executives. Chief Scientific Officer Kevin Church sold 8,526 shares at $0.29 per share on July 1, 2025, while Director, President and CEO Mark James Litton sold 25,123 shares at the same price on the same date. SVP of Finance and Accounting Robert Renninger sold 2,897 shares at $0.29 per share on July 1, 2025, and also purchased 10,000 shares at $0.23 per share on May 19, 2025. Chief Medical Officer Javier San Martin sold 10,842 shares at $0.29 per share on July 1, 2025, and General Counsel and CCO Mark Worthington sold 8,526 shares at $0.29 per share on the same date.